|
Volumn 7, Issue 1, 2009, Pages 26-28
|
Regulation of drug pricing in Australia, England, and New Zealand
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
AUSTRALIA;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DRUG COST;
DRUG FORMULARY;
DRUG LEGISLATION;
DRUG MARKETING;
GOVERNMENT REGULATION;
HEALTH CARE FINANCING;
HEALTH CARE ORGANIZATION;
HUMAN;
LIFE EXPECTANCY;
NEW ZEALAND;
OUTCOME ASSESSMENT;
PRIMARY HEALTH CARE;
QUALITY ADJUSTED LIFE YEAR;
REFERENCE VALUE;
UNITED KINGDOM;
UNITED STATES;
ECONOMICS;
INTERVIEW;
LEGAL ASPECT;
DRUG;
AUSTRALIA;
DRUG COSTS;
ENGLAND;
HUMANS;
NEW ZEALAND;
PHARMACEUTICAL PREPARATIONS;
|
EID: 63449107209
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (1)
|